Molecular Therapy: Nucleic Acids

2162-2531 (Print)

Website

About

Publishing with this journal

Expect on average 20 weeks from submission to publication.

Best practice

The author does not retain unrestricted copyrights and publishing rights.

→ Learn more about their copyright policy.

Articles digitally archived in:

  • CLOCKSS

→ Find out about their archiving policy.

Permanent article identifier:

  • DOI

Journal metadata

Publisher
Elsevier, United States
Society or institution
American Society of Gene & Cell Therapy
Manuscripts accepted in
English